PROMPT depression
Toward PRecisiOn Medicine for the Prediction of Treatment Response in Major Depressive Disorder through Stratification of Combined Clinical and -Omics Signatures
Medical Need
Major depressive disorder (MDD) is the most common psychiatric disease worldwide and represents a leading cause of years lived with disability. A high number of MDD patients do not achieve response to antidepressant treatment and a full symptomatologic remission with functional recovery, representing a huge economic burden for the health public systems.
PROMPT Objectives
It is extremely relevant to identify predictive markers at different levels (stratification of clinical features, genetic and gene expression profiles) and to integrate all this information for its use in “real-world” settings.
PROMPT Impact
The perspective is to design future clinical trials in which the prediction provided by the integration of clinical and -omics signatures will be used to drive decision making by the clinicians as well as patients perspectives.
The PROMPT project
This project has a unique personalized medicine approach addressing an important and large medical burden: treatment resistance in MDD
European network
The project connects experts in different complementary disciplines (clinical psychiatry, -omics sciences, bioinformatics, modelling) from different European countries
PROMPT is committed to fostering gender balance in research teams, ensuring gender balance in decision-making, and integrating the gender dimension in research and innovation.
Learn about depression
Major depressive disorder (MDD)
News and Featured Work
No news yet
Contact us
Need information ? Email Us!